UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diffuse Infiltrating Oligodendroglioma and Astrocytoma

Journal of clinical oncology, 2017-07, Vol.35 (21), p.2394-2401

2017

Volltextzugriff (PDF)

Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)

Neuro-oncology (Charlottesville, Va.), 2017-02, Vol.19 (2), p.162-174

2017

Volltextzugriff (PDF)

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis

Neuro-oncology (Charlottesville, Va.), 2018-01, Vol.20 (1), p.103-112

2018

Volltextzugriff (PDF)

International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

Brain pathology (Zurich, Switzerland), 2014-09, Vol.24 (5), p.429-435

2014

Volltextzugriff (PDF)

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Journal of clinical oncology, 2013-01, Vol.31 (3), p.344-350

2013

Volltextzugriff (PDF)

A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics

Neuro-oncology (Charlottesville, Va.), 2017-05, Vol.19 (5), p.614-624

2017

Volltextzugriff (PDF)

Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas

Neuro-oncology (Charlottesville, Va.), 2015-07, Vol.17 (7), p.935-941

2015

Volltextzugriff (PDF)

Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol

PloS one, 2017-09, Vol.12 (9), p.e0184895-e0184895

2017

Volltextzugriff (PDF)

MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma

The New England journal of medicine, 2005-03, Vol.352 (10), p.997-1003

2005

Volltextzugriff (PDF)

Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification

Acta neuropathologica, 2017-12, Vol.134 (6), p.957-959

2017

Volltextzugriff (PDF)

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial

European journal of cancer (1990), 2018-05, Vol.94, p.168-178

2018

Volltextzugriff (PDF)

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial

Neuro-oncology (Charlottesville, Va.), 2016-03, Vol.18 (3), p.388-400

2016

Volltextzugriff (PDF)

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1268-1274

2009

Volltextzugriff (PDF)

Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigens

Scientific reports, 2019-10, Vol.9 (1), p.14643-11, Article 14643

2019

Volltextzugriff (PDF)

Unlocking molecular mechanisms and identifying druggable targets in matched-paired brain metastasis of breast and lung cancers

Frontiers in immunology, 2023-12, Vol.14, p.1305644-1305644

2023

Volltextzugriff (PDF)

Circulating glioma biomarkers

Neuro-oncology (Charlottesville, Va.), 2015-03, Vol.17 (3), p.343-360

2015

Volltextzugriff (PDF)

Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma

European journal of nuclear medicine and molecular imaging, 2023-03, Vol.50 (4), p.1195-1204

2023

Volltextzugriff (PDF)

Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen?

Acta neuropathologica communications, 2023-04, Vol.11 (1), p.64-64, Article 64

2023

Volltextzugriff (PDF)

Metabolic changes related to the IDH1 mutation in gliomas preserve TCA‐cycle activity: An investigation at the protein level

The FASEB journal, 2020-03, Vol.34 (3), p.3646-3657

2020

Volltextzugriff (PDF)

Approved CAR T cell therapies: ice bucket challenges on glaring safety risks and long-term impacts

Drug discovery today, 2018-06, Vol.23 (6), p.1175-1182

2018

Volltextzugriff (PDF)

Detection of Meningioma in Dura Mater by Raman Spectroscopy

Analytical chemistry (Washington), 2005-12, Vol.77 (24), p.7958-7965

2005

Volltextzugriff (PDF)

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

Journal of clinical oncology, 2009-12, Vol.27 (35), p.5881-5886

2009

Volltextzugriff (PDF)

CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions

Arteriosclerosis, thrombosis, and vascular biology, 2017-06, Vol.37 (6), p.1098-1114

2017

Volltextzugriff (PDF)

Novel Antibody-Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma

International journal of molecular sciences, 2022-05, Vol.23 (9), p.5061

2022

Volltextzugriff (PDF)

1 – 25 von 655

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(618)
Mit Volltextzugriff
(599)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neuro-Oncology
(67)
Journal Of Neuropathology And Experimental Neurology
(32)
Journal Of Clinical Oncology
(25)
Acta Neuropathologica
(17)
Journal Of Neuro-Oncology
(14)
Brain Pathology
(13)
Cancer
(13)
Cancer Research
(13)
Angewandte Chemie
(12)
Annals Of Neurology
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Diffuse Infiltrating Oligodendroglioma and Astrocytoma

Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis

International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics

Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas

Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol

MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma

Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigens

Unlocking molecular mechanisms and identifying druggable targets in matched-paired brain metastasis of breast and lung cancers

Circulating glioma biomarkers

Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma

Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen?

Metabolic changes related to the IDH1 mutation in gliomas preserve TCA‐cycle activity: An investigation at the protein level

Approved CAR T cell therapies: ice bucket challenges on glaring safety risks and long-term impacts

Detection of Meningioma in Dura Mater by Raman Spectroscopy

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions

Novel Antibody-Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma

Suchergebnisse filtern